These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6713622)

  • 21. [Aluminum in chronic renal failure].
    Głuszek J; Adamczak H
    Rocz Panstw Zakl Hig; 1993; 44(1):43-8. PubMed ID: 8235341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aluminum metabolism and toxicity in renal failure: a review.
    Mayor GH; Lohr TO; Sanchez TV
    J Environ Pathol Toxicol Oncol; 1985; 6(1):43-50. PubMed ID: 3906081
    [No Abstract]   [Full Text] [Related]  

  • 23. Desferrioxamine in the treatment of aluminum overload.
    Ackrill P; Day JP
    Clin Nephrol; 1985; 24 Suppl 1():S94-7. PubMed ID: 3842106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialysis encephalopathy secondary to aluminum toxicity, diagnosed by bone biopsy.
    Andrade LG; Garcia FD; Silva VS; Gabriel DP; Rodrigues AG; Nascimento GV; Caramori JT; Martin LC; Barretti P; Balbi AL
    Nephrol Dial Transplant; 2005 Nov; 20(11):2581-2. PubMed ID: 16105866
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients.
    Bakir AA; Hryhorczuk DO; Berman E; Dunea G
    ASAIO Trans; 1986; 32(1):171-6. PubMed ID: 3778707
    [No Abstract]   [Full Text] [Related]  

  • 26. [Aluminum poisoning].
    Cervar M; Stavljenic A; Vukicević S
    Lijec Vjesn; 1989; 111(4-5):164-9. PubMed ID: 2671563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aluminum-related osteodystrophy.
    Sherrard DJ; Andress DL
    Adv Intern Med; 1989; 34():307-23. PubMed ID: 2644762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
    Lillevang ST; Pedersen FB
    Nephrol Dial Transplant; 1989; 4(7):676. PubMed ID: 2510071
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention and treatment of aluminum intoxication in chronic renal failure.
    Simon P; Allain P; Ang KS; Cam G; Mauras Y
    Adv Nephrol Necker Hosp; 1985; 14():439-78. PubMed ID: 3919543
    [No Abstract]   [Full Text] [Related]  

  • 30. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 31. Ultrastructural localization of aluminum in patients with dialysis-associated osteomalacia.
    Verbueken AH; Van de Vyver FL; Van Grieken RE; Paulus GJ; Visser WJ; D'Haese P; De Broe ME
    Clin Chem; 1984 May; 30(5):763-8. PubMed ID: 6713639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy.
    Felsenfeld AJ
    ANNA J; 1985 Jun; 12(3):189-91. PubMed ID: 3848318
    [No Abstract]   [Full Text] [Related]  

  • 33. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
    Sprague SM; Corwin HL; Wilson RS; Mayor GH; Tanner CM
    Arch Intern Med; 1986 Oct; 146(10):2063-4. PubMed ID: 3767553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aluminic intoxication in chronic hemodialysis. A diagnosis rarely evoked nowadays. Clinical case and review of the literature].
    Seidowsky A; Dupuis E; Drueke T; Dard S; Massy ZA; Canaud B
    Nephrol Ther; 2018 Feb; 14(1):35-41. PubMed ID: 29174672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal osteodystrophy.
    Bardin T
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):114S-118S. PubMed ID: 9273952
    [No Abstract]   [Full Text] [Related]  

  • 36. Aluminum toxicity.
    Berlyne GM; Yagil R
    Lancet; 1972 Jul; 2(7766):47. PubMed ID: 4113645
    [No Abstract]   [Full Text] [Related]  

  • 37. Aluminum in the joint tissues of chronic renal failure patients treated with regular hemodialysis and aluminum compounds.
    Netter P; Kessler M; Burnel D; Hutin MF; Delones S; Benoit J; Gaucher A
    J Rheumatol; 1984 Feb; 11(1):66-70. PubMed ID: 6699835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Speech apraxia in dialysis-associated aluminum encephalopathy].
    Haug BA; Botsch G; Felgenhauer K
    Nervenarzt; 1991 Oct; 62(10):637-40. PubMed ID: 1749454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients.
    Sprague SM; Corwin HL; Tanner CM; Wilson RS; Green BJ; Goetz CG
    Arch Intern Med; 1988 Oct; 148(10):2169-72. PubMed ID: 3178374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of dialysis encephalopathy.
    Arieff AI; Mahoney CA
    Neurobehav Toxicol Teratol; 1983; 5(6):641-4. PubMed ID: 6366603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.